Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cutting antibiotic use has no adverse affect on cattle health and welfare - study 
The growing threat of antimicrobial resistance has put pressure on the livestock industry to reduce its use of antibiotics.
Researchers analyse data from seven dairy farms

Ceasing the use of certain antibiotics does not have an adverse effect on the health, welfare or production of dairy cows, according to new research.

In the study, researchers collected data from seven dairy farms in North Somerset that had stopped using the ‘highest priority critically important antimicrobials’ (HP-CIAs), as recommended by the World Health Organisation.

The findings, published in Vet Record, suggest that the health and welfare of dairy cattle can be maintained - and even improved - without the use of HP-CIAs. They also indicate that the complete cessation of HP-CIAs can lead to an overall reduction of antibiotic use on dairy farms.

“A cessation of the use of HP-CIAs and a decrease in the use of AMs within the livestock industry should be a key target for farmers and veterinary surgeons and has been shown to be achievable while maintaining animal health, welfare and production,” the authors conclude.

The growing threat of antimicrobial resistance to both human and animal health has put pressure on the livestock industry to reduce its use of antibiotics. In April 2017, the World Health Organisation identified quinolines and third- and fourth- generation cephalosporins as HP-CIAs because of the level of risk to human health.

The study, Ceasing the use of the highest priority critically important antimicrobials does not adversely affect production, health or welfare parameters in dairy cows, was conducted by veterinary researchers at the University of Bristol and the University of Surrey.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'